Patents by Inventor David Piper

David Piper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6981660
    Abstract: A pneumatic inhaler that is able to deliver a controlled burst or dose of aerosol from a reservoir of liquid or powder medication. A supersonic jet of gas is emitted from a nozzle and shock waves are developed in the jet. In one embodiment the supersonic jet is directed into a shock chamber. Liquid or micronized powder material is introduced into the supersonic jet to form an aerosol. In one embodiment, smaller aerosol particles are separated from larger aerosol particles with a separator. In another embodiment, the produced aerosol is contained in an aerosol storage chamber prior to inhalation by the users.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: January 3, 2006
    Assignee: Evit Labs
    Inventor: Samuel David Piper
  • Publication number: 20040195364
    Abstract: A pneumatic inhaler that is able to deliver a controlled burst or dose of aerosol from a reservoir of liquid medication. The inhaler is suitable for the aerosolization of liquid medication that is in solution or suspension form. The inhaler is also ideal for the delivery of unique and specialty liquid medications in short aerosol bursts because no additional formulation development is needed and has the further advantage of being able to deliver multiple medications, as mixed by the patient, doctor, or pharmacist, with a single burst at a repeatable output. Because medication and propellant are not mixed until aerosolization occurs, the inhaler is appropriate for more pharmaceutical agents than the current inhalers available and at a substantial cost savings.
    Type: Application
    Filed: March 30, 2004
    Publication date: October 7, 2004
    Inventor: Samuel David Piper
  • Patent number: 6742721
    Abstract: A pneumatic inhaler that is able to deliver a controlled burst or dose of aerosol from a reservoir of liquid medication. The inhaler is suitable for the aerosolization of liquid medication that is in solution or suspension form. The inhaler is also ideal for the delivery of unique and specialty liquid medications in short aerosol bursts because no additional formulation development is needed and has the further advantage of being able to deliver multiple medications, as mixed by the patient, doctor, or pharmacist, with a single burst at a repeatable output. Because medication and propellant are not mixed until aerosolization occurs, the inhaler is appropriate for more pharmaceutical agents than the current inhalers available and at a substantial cost savings.
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: June 1, 2004
    Assignee: Evit Laboratories
    Inventor: Samuel David Piper
  • Publication number: 20040050966
    Abstract: A pneumatic inhaler that is able to deliver a controlled burst or dose of aerosol from a reservoir of liquid or powder medication. A supersonic jet of gas is emitted from a nozzle and shock waves are developed in the jet. In one embodiment the supersonic jet is directed into a shock chamber. Liquid or micronized powder material is introduced into the supersonic jet to form an aerosol. In one embodiment, smaller aerosol particles are separated from larger aerosol particles with a separator. In another embodiment, the produced aerosol is contained in an aerosol storage chamber prior to inhalation by the users.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 18, 2004
    Inventor: Samuel David Piper
  • Patent number: 6664229
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose or treat diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: December 16, 2003
    Assignee: SmithKline Beecham p.l.c.
    Inventors: James Joseph Hagan, Jonathan Alexander Terrett, Neil Upton, David Piper, Martin Ian Smith, Guy Anthony Kennett, Saraswati R. Patel
  • Publication number: 20030087801
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose or treat diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Application
    Filed: December 15, 1998
    Publication date: May 8, 2003
    Inventors: JAMES JOSEPH HAGAN, JONATHAN ALEXANDER TERRETT, NEIL UPTON, DAVID PIPER, MARTIN IAN SMITH, GUY ANTHONY KENNETT, SARASWATI R. PATEL
  • Patent number: 6390090
    Abstract: An inhalation therapy device includes a collapsible aerosol storage bag (7) having an opening which connects to the end of a dual port member, one port (8) of which is in fluid communication with a nebulizer. During patient exhalation the aerosol storage bag becomes partially inflated with exhaled gas during the first part of exhalation. The laminar coherent aerosol jet exits the dual port member and remains coherent until reaching the end of the aerosol storage bag, at which time it diverges and expels all exhaled gas from the aerosol storage bag, thus filling the aerosol storage bag with aerosol. All escaping gas exits the aerosol storage bag via the remaining port (9) of the dual port member, where it escapes into the ambient environment through the ambient port. The remaining dual port of the dual port member, in addition to providing means for escaping gas from the aerosol storage bag, is also in fluid communication with the ambient port and the mouthpiece (1).
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: May 21, 2002
    Inventor: Samuel David Piper
  • Publication number: 20020056760
    Abstract: A pneumatic inhaler that is able to deliver a controlled burst or dose of aerosol from a reservoir of liquid medication. The inhaler is suitable for the aerosolization of liquid medication that is in solution or suspension form. The inhaler is also ideal for the delivery of unique and specialty liquid medications in short aerosol bursts because no additional formulation development is needed and has the further advantage of being able to deliver multiple medications, as mixed by the patient, doctor, or pharmacist, with a single burst at a repeatable output. Because medication and propellant are not mixed until aerosolization occurs, the inhaler is appropriate for more pharmaceutical agents than the current inhalers available and at a substantial cost savings.
    Type: Application
    Filed: September 25, 2001
    Publication date: May 16, 2002
    Applicant: EVIT LABS
    Inventor: Samuel David Piper
  • Patent number: 6338443
    Abstract: A pneumatic nebulizer that produces a high volume of aerosols for inhalent delivery of medications and other constituencies. High pressure gas formed into a gas jet is passed through a thin choked region of fluid that is entrailed and impinged upon an aerosol amplifier which creates a spray whose aerosol components are directed up through vents to an aerosol outlet for delivery. Larger-sized liquid particles are caused to pool up in a region surrounding the aerosol amplifer and then drip down back into the liquid medication reservoir.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: January 15, 2002
    Assignee: Mercury Enterprises, Inc.
    Inventor: Samuel David Piper
  • Patent number: 6067984
    Abstract: A dual area pressure pulmonary modulator apparatus which provides constant flow, pressure cycled ventilatory support to patients. The pressure pulmonary modulator apparatus opens at a selected pressure and shuts at a substantially lower pressure. The pressure pulmonary modulator apparatus can be incorporated into an automatic resuscitator suited for providing ventilatory support during resuscitation and/or transport of patients. The automatic resuscitator may be combined with a nebulizer to serve as a positive pressure aerosol therapy device. The pressure pulmonary modulator apparatus can also be incorporated into a percussive therapy device used for the mobilization of mucus in patients. The pressure pulmonary modulator apparatus may be made almost entirely of injection molded plastic and is inexpensive, portable and disposable.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: May 30, 2000
    Inventor: Samuel David Piper
  • Patent number: 5760787
    Abstract: A method and apparatus for storing data defining a graphical outline of an object, the graphical outline comprising a series of curve segments. First, those curve segments which comprise straight line segments are determined. The method next stores a first number of associated control points for each of said curve segments which do not comprise straight line segments. The method then operates to store a reduced number of associated control points for each of the curve segments which comprise straight line segments.
    Type: Grant
    Filed: August 17, 1995
    Date of Patent: June 2, 1998
    Assignees: Canon Information Systems Research Australia, PTY Ltd., Canon Kabushiki Kaisha
    Inventor: Anthony David Piper